High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
Year: 1988
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: W P Peters, E J Shpall, R B Jones, G A Olsen, R C Bast, J P Gockerman, J O Moore
Institution: Duke Medical Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2276085691